Odyssey Health (ODYY) Long-Term Investments (2017 - 2025)
Odyssey Health (ODYY) posted quarterly Long-Term Investments of $97149.0 for Q2 2025, down 99.28% year-over-year from $13.4 million in Q2 2024, and down 38.71% quarter-over-quarter from $158505.0 in Q1 2025.
Odyssey Health (ODYY) Long-Term Investments (2017 - 2025) Analysis & Trends
Odyssey Health's Long-Term Investments history runs 3 years deep, the most recent figure standing at $97149.0 for Q2 2025.
- In Q2 2025, Long-Term Investments fell 99.28% year-over-year to $97149.0; the TTM figure through Apr 2025 stood at $97149.0 (down 99.28% YoY), while the FY2024 annual figure was $529203.0, changed N/A from the prior year.
- Long-Term Investments for Q2 2025 stood at $97149.0, down from $158505.0 in the prior quarter.
- The five-year high for Long-Term Investments was $13.8 million in Q1 2024, with the low at $97149.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | - |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 97,149.00 |
| Jan 31, 2025 | 158,505.00 |
| Oct 31, 2024 | 158,505.00 |
| Jul 31, 2024 | 529,203.00 |
| Apr 30, 2024 | 13.42 Mn |
| Jan 31, 2024 | 13.79 Mn |
| Oct 31, 2017 | 130,395.00 |
| Jul 31, 2017 | 107,157.00 |